Setback to Roche: Plea Against Natco on Risdiplam Patent Rejected by Delhi HC Farhat Nasim25 March 2025 12:01 PMNew Delhi: In a major relief to Indian drugmaker Natco Pharma, the Delhi High Court has rejected an interim injunction plea filed by Swiss...
submit phase I and phase II data for Crohn's disease: CDSCO Panel tells Roche Products India on RO7790121 study Dr. Divya Colin22 March 2025 12:30 PMNew Delhi: Reviewing Phase III clinical study protocol of the monoclonal antibody RO7790121, the Subject Expert Committee (SEC) functional under the...
Roche, Zealand Pharma ink pact to co-develop, co-commercialise petrelintide as foundational therapy for obesity Ruchika Sharma14 March 2025 8:00 AMBasel: Roche has announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma. Under the terms of this...
Conduct Phase III CT in Indian population: CDSCO Panel tells Roche Products India on Baloxavir marboxil Dr. Divya Colin6 March 2025 12:30 PMNew Delhi: Noting that the Indian patient’s clinical data is not sufficient and acute uncomplicated influenza is not an unmet medical need, the...
Roche Gazyva application accepted by USFDA for lupus nephritis Ruchika Sharma5 March 2025 8:15 AMGazyva/Gazyvaro is an anti-CD20 monoclonal antibody in a randomised phase III study to demonstrate a CRR benefit in lupus nephritis.
USFDA Approves Roche's Evrysdi Tablet for Spinal Muscular Atrophy Farhat Nasim15 Feb 2025 5:15 AMEvrysdi is the only non-invasive disease-modifying treatment for SMA.
Roche bags USFDA nod for companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for Enhertu Ruchika Sharma1 Feb 2025 7:00 AMBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for the PATHWAY anti-HER2/neu (4B5)...
Roche names Wafaa Mamilli as Chief Digital Technology Officer Ruchika Sharma31 Jan 2025 8:00 AMBasel: Roche has announced that Wafaa Mamilli will join the company as Chief Digital Technology Officer (CDTO), reporting to Group CEO, Thomas...
Roche receives USFDA clearance with CLIA waiver for cobas liat sexually transmitted infection multiplex assay panels Ruchika Sharma26 Jan 2025 5:00 AMBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory Improvement...
Roche gets USFDA clearance for highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma Ruchika Sharma14 Jan 2025 10:36 AMBasel: Roche has announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its...
Roche has no plans for job cuts and business is healthy: CEO Ruchika Sharma31 Dec 2024 11:18 AMPharmaceutical giant Roche has no plans for workforce reductions and the company's business is healthy, CEO Thomas Schinecker was...
Pfizer, AstraZeneca and several other drugmakers in race to join weight loss drug market Ruchika Sharma23 Dec 2024 11:31 AMPfizer, AstraZeneca, Amgen and several other drug developers aiming to join the weight-loss drug market, which is estimated to be worth about $150...
